Workflow
Tiziana Life Sciences expands Phase 2 MS trial to fifth site, commences patient dosing
Proactiveinvestors NA· 2025-06-13 15:03
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Plug Power Down 39% YTD: How Should Investors Play the Stock?
ZACKS· 2025-06-13 15:01
Key Takeaways PLUG stock has plunged 39% YTD amid declining hydrogen infrastructure sales and negative gross margins. Revenues rose 11.1% in Q1 2025, helped by stronger electrolyzer sales and materials-handling demand. Cash burn fell 50% year over year as PLUG launched Project Quantum Leap to drive $200M in annualized savings.Plug Power Inc. (PLUG) , a prominent name in the green hydrogen industry, has seen a 39% plunge in its stock price in the year-to-date period, underperforming the industry as well as ...
CrowdStrike's Renewed Growth Opportunity Has Been Overbought
Seeking Alpha· 2025-06-13 15:00
I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
Prnewswire· 2025-06-13 15:00
Phase 1b study suggests a promising safety profile and highlights the potential of a novel dual-targeting CD19/CD20 CAR T in patients with relapsed or refractory disease75-80% complete response rate among evaluable patients at the recommended Phase 2 dose  MILAN, June 13, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19/CD20 bispecific autologous chimeric antigen ...
Compass Diversified (CODI) Faces Crisis as Lugano Scandal Forces Downgrade, Investor Lawsuit – Hagens Berman
GlobeNewswire News Room· 2025-06-13 14:58
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Compass Diversified’s (NYSE: CODI) tumultuous spring continued as Jefferies analysts recently downgraded the company’s stock amid a sweeping securities class action lawsuit filed by investors, both moves stemming from a widening accounting scandal at its Lugano subsidiary.  The dual blows—Wall Street’s loss of confidence and mounting legal challenges—have sent Compass’s shares into a tailspin, erasing over 70% of the company’s market value over the past three ...
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 FY26
Newsfile· 2025-06-13 14:57
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 FY26June 13, 2025 10:57 AM EDT | Source: Reportable, Inc. Dallas, Texas--(Newsfile Corp. - June 13, 2025) - Hooker Furniture Corporation (NASDAQ: HOFT): Stonegate Capital Partners updates their coverage on Hooker Furniture Corporation (NASDAQ: HOFT). HOFT reported revenue, operating income, and adj EPS of $85.3M, ($3.6)M, and ($0.29), respectively. This compares to our/consensus estimates of $92.6M/$88.9M, ($2.5)M/($2.5)M, an ...
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
ZACKS· 2025-06-13 14:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...
Here's Why CF Industries (CF) is a Strong Momentum Stock
ZACKS· 2025-06-13 14:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...
UNM Stock Trading at a Discount to Industry at 1.23X: Time to Hold?
ZACKS· 2025-06-13 14:56
Key Takeaways For 2025, Unum U.S. expects sales growth of 5-10% and an adjusted operating ROE of 23-25%. For 2025, Colonial Life projects 5-10% sales growth and 18-20% ROE. Favorable sales trends, risk experience, persistency, and capital strength position UNM for long-term growth.Unum Group (UNM) shares are trading at a discount compared to the Zacks Accident and Health Insurance industry. Its forward price-to-book value of 1.23X is lower than the industry average of 1.82X, the Finance sector’s 4.16X and ...
Bears are Losing Control Over Molina (MOH), Here's Why It's a 'Buy' Now
ZACKS· 2025-06-13 14:56
Shares of Molina (MOH) have been struggling lately and have lost 6.5% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the ...